N
ONEM

Nuveen’s 1Life Healthcare ONEM Stock Holding History

Nuveen’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,295,010
Closed -$21.6M – 3170
2022
Q4 		$21.6M Buy
1,295,010
+69,221
+6% +$1.17M 0.01% 983
2022
Q3 		$21M Sell
1,225,789
-127,484
-9% -$2M 0.01% 980
2022
Q2 		$10.6M Buy
1,353,273
+565,163
+72% +$4.86M ﹤0.01% 1465
2022
Q1 		$8.03M Sell
788,110
-75,183
-9% -$842K ﹤0.01% 1784
2021
Q4 		$15.2M Sell
863,293
-37,748
-4% -$732K ﹤0.01% 1416
2021
Q3 		$18.2M Sell
901,041
-194,083
-18% -$4.99M 0.01% 1330
2021
Q2 		$36.2M Buy
1,095,124
+182,777
+20% +$6.9M 0.01% 936
2021
Q1 		$35.7M Buy
912,347
+151,482
+20% +$7.11M 0.01% 924
2020
Q4 		$33.2M Buy
760,865
+137
+0% +$4.68K 0.01% 921
2020
Q3 		$21.6M Buy
760,728
+408,601
+116% +$12.9M 0.01% 1010
2020
Q2 		$12.8M Buy
352,127
+289,795
+465% +$8.16M 0.01% 1319
2020
Q1 		$1.13M Buy
+62,332
New +$1.37M ﹤0.01% 2464

Nuveen's ONEM Position: Q1 2023 in Review

Nuveen sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,295,010 shares — an estimated $21.6M sold.

Nuveen first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $36.2M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Nuveen reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Nuveen sold 1,295,010 1Life Healthcare shares in Q1 2023, an estimated $21.6M.
  • Nuveen first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Nuveen's 1Life Healthcare position peaked at $36.2M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.